Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Acadia Healthcare Company Inc. (ACHC)

NASDAQ: ACHC · Services-Specialty Outpatient Facilities, NEC · Franklin, TN

Our rating: Cautious

Cautious reaffirmed at $32.25, high conviction, November 4, 2026.

Breaks if: The Cautious view is wrong if Acadia reports trailing-twelve-month free cash flow above zero across any two consecutive quarterly filings within the next 12 months — a genuine, sustained reversal from the current -$440M run rate. A stock that sustains above $46 (roughly 43% above today's level) over a 12-month window would signal the market has priced in a recovery the current figures do not support, and would warrant a fresh read of the thesis.

Key figures

Market value$3.2B
Revenue, last 12 months$3.4B
Net income, last 12 months−$1.1B
Free cash flow, last 12 months−$24M
Price to earningsn/a
Free cash flow yield−0.7%
Dividend yield0.0%
Operating marginn/a
Return on equity−43.9%
Beta to the S&P 5000.69
Volatility, annualized59.8%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$895M5.1%$0.38$47M
June 30, 2026$866M−0.4%$0.12$124M
March 31, 2026$829M7.6%$0.05−$15M
December 31, 2025$821M6.1%$-12.98−$179M
September 30, 2025$852M4.4%$0.40−$63M
June 30, 2025$869M9.2%$0.33−$34M
March 31, 2025$771M0.3%$0.09−$163M
December 31, 2024$774M4.2%$0.36−$87M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

14 ledger entries and 71 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.